menu search

Charles river (crl) to report q3 earnings: what's in store?

Charles River's (crl) CRADLE initiative and research models in North America and China are anticipated ...

November 1, 2023, 10:33 am

Immunitybio: the crl makes it riskier than ever

ImmunityBio, Inc.'s drug Anktiva received a Complete Response Letter, or crl, from the FDA, delaying it...

October 24, 2023, 2:38 pm

Why charles river (crl) could beat earnings estimates again

Charles River (crl) has an impressive earnings surprise history and currently possesses the right combi...

October 24, 2023, 1:32 pm

Alnylam pharmaceuticals: a good buy ahead of phase 3 data for vutrisiran

We rate Alnylam Pharmaceuticals, Inc.'s common stock a Buy on the dip after the complete response letter, crl<...

October 13, 2023, 6:11 pm

Alnylam (alny) receives crl for the label expansion of onpattro

Alnylam's (ALNY) label expansion-seeking application for Onpattro, to treat transthyretin-mediated amyloidosis with cardiomyopathy, gets the FDA's ...

October 10, 2023, 12:01 pm

Here's why you should retain charles river (crl) stock now

Investors are optimistic about Charles River (crl) on robust RMS segment growth and upbeat guidance....

October 10, 2023, 10:31 am

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of ars pharmaceuticals, inc. (spry)

NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of ARS Pharmaceuticals, Inc. (...

October 5, 2023, 4:08 pm

Lilly's (lly) eczema candidate lebrikizumab faces fda rejection

Lilly (LLY) gets a crl for the eczema candidate, lebrikizumab, based on inspection findings at a third-...

October 3, 2023, 9:01 am

Charles river (crl) launches lvv-based gene therapy platform

Charles River's (crl) LVV platform provides medicinal developers with an efficient, dependable route to...

October 2, 2023, 12:46 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of ars pharmaceuticals, inc.

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of ARS Pharmaceuticals, Inc. ...

September 26, 2023, 8:40 pm

Charles river (crl) opens a rightsource lab in stevenage

Charles River's (crl) new RightSource facility is likely to provide services to the Stevenage advanced ...

September 26, 2023, 9:46 am

Ars pharmaceuticals vs. aquestive therapeutics; neffy crl creates an opportunity for investing in both

Both ARS Pharmaceuticals and Aquestive Therapeutics are developing non-injectable epinephrine products for anaphylaxis, with potential to capture sign...

September 22, 2023, 7:18 pm

Ars pharmaceuticals stock falls toward record selloff after fda issues surprise crl, requesting additional studies

Sharesof ARS Pharmaceuticals Inc. SPRY plunged 46.9% toward a 15-month low in premarket trading Wednesday, after the biopharmaceutical company said th...

September 20, 2023, 6:21 am

Charles river (crl) announces partnership with related sciences

Charles River's (crl) new collaboration is likely to leverage the AI-powered drug discovery and develop...

September 15, 2023, 9:46 am

New york cannabis regulators vote to allow multistate operators into the market

New York's adult-use cannabis market is set to expand with the addition of multi-state operators The New York Cannabis Control Board voted Tuesday to ...

September 13, 2023, 12:21 pm

Here's why you should retain charles river (crl) stock now

Investors are optimistic about Charles River (crl) on the RMS segment's continued growth and upbeat gui...

September 6, 2023, 12:01 pm

Astrazeneca (azn) gets fda crl for ultomiris in new indication

AstraZeneca (AZN) said the crl for Ultomiris for NMOSD indication does not raise any concerns about the...

September 6, 2023, 11:18 am

Outlook therapeutics® provides regulatory update on fda review of ons-5010 / lytenava™ (bevacizumab-vikg) for the treatment of wet amd

FDA issues Complete Response Letter (crl) for ONS-5010 BLA based on CMC and need for further confirmato...

August 30, 2023, 10:00 am

Outlook therapeutics' stock tumbles 71% premarket after fda rejects treatment for wet amd

Outlook Therapeutics Inc.'s stock OTLK, +10.16% tumbled 71% in premarket trade Wednesday, after the company said the U.S. Food and Drug Administration...

August 30, 2023, 6:29 am

Charles river (crl) collaborates with fondazione telethon

Charles River (crl) is excited about Fondazione Telethon's collaboration to produce HQ plasmid DNA for ...

August 25, 2023, 12:02 pm


Search within

Pages Search Results: